Literature DB >> 2430975

The melanoma proteoglycan: restricted expression on microspikes, a specific microdomain of the cell surface.

H J Garrigues, M W Lark, S Lara, I Hellström, K E Hellström, T N Wight.   

Abstract

A cell surface chondroitin sulfate proteoglycan associated with human melanomas and defined by mAb's F24.47 and 48.7 has been characterized biochemically and localized by indirect immunogold electron microscopy. These antibodies recognize distinct epitopes on the intact proteoglycan. In addition, mAb 48.7 also recognizes an epitope on a 250,000-D glycoprotein and is therefore similar to antibody 9.2.27 (described by Bumol, T.F., and R.A. Reisfeld, 1982, Proc. Natl. Acad. Sci. USA., 79:1245-1249). Furthermore, it was shown that the glycosaminoglycan chains released by alkaline borohydride treatment of the proteoglycan recognized by mAb 48.7 had a size of approximately 60,000 D. Since the intact proteoglycan was estimated to be 420,000 D, there are probably three chondroitin sulfate chains attached to the 250,000-D core glycoprotein. Furthermore, an oligosaccharide fraction containing 42% of the 3H activity (glucosamine as precursor) was isolated. Immunolocalization studies using whole-mount electron microscopy revealed that the chondroitin sulfate proteoglycan was present almost exclusively on microspikes, a microdomain of the melanoma cell surface. These processes were present as 1-2-micron structures on the upper cell surface and as longer (up to 20 micron) structures at the cell periphery. Peripheral microspikes were involved in the initial interactions between adjacent cells and formed complex footpads that made contact with the substratum. Immunogold-labeled cells were also thin sectioned and the specific localization of the chondroitin sulfate proteoglycan antigen was quantitated. The data confirmed the results of whole-mount microscopy and demonstrated a statistically significant association of the antigen with the microspike processes as compared with other areas of the cell surface. By using two different mAb's (48.7 and F24.47) that recognize epitopes on either the core glycoprotein or the intact proteoglycan, respectively, we have demonstrated that both molecules have the same restricted distribution at the cell surface. The specific localization of the antigen to microspikes at the cell surface suggests it may play a role in cell-cell contact and cell-substratum adhesion, which could be important in the metastatic process.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430975      PMCID: PMC2114375          DOI: 10.1083/jcb.103.5.1699

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  61 in total

1.  Detachment variants of Chinese hamster cells. Hyaluronic acid as a modulator of cell detachment.

Authors:  B J Barnhart; S H Cox; P M Kraemer
Journal:  Exp Cell Res       Date:  1979-03-15       Impact factor: 3.905

2.  Codistribution of pericellular matrix proteins in cultured fibroblasts and loss in transformation: fibronectin and procollagen.

Authors:  A Vaheri; M Kurkinen; V P Lehto; E Linder; R Timpl
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

3.  Isolation and characterization of proteoglycans from human chondrosarcomas.

Authors:  S Pal; W Strider; R Margolis; G Gallo; S Lee-Huang
Journal:  J Biol Chem       Date:  1978-02-25       Impact factor: 5.157

4.  Fibronectin and proteoglycans as determinants of cell-substratum adhesion.

Authors:  L A Culp; B A Murray; B J Rollins
Journal:  J Supramol Struct       Date:  1979

5.  Cell surface antigens of human melanoma identified by monoclonal antibody.

Authors:  M Y Yeh; I Hellström; J P Brown; G A Warner; J A Hansen; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

6.  Melanoma localization in nude mice with monoclonal Fab against p97.

Authors:  P L Beaumier; K A Krohn; J A Carrasquillo; J Eary; I Hellström; K E Hellström; W B Nelp; S M Larson
Journal:  J Nucl Med       Date:  1985-10       Impact factor: 10.057

7.  Glycosaminoglycans and proteoglycans of normal and tumoral cartilages of humans and rats.

Authors:  P A Mourão; Y M Michelacci; O M Toledo
Journal:  Cancer Res       Date:  1979-07       Impact factor: 12.701

8.  Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms.

Authors:  R G Woodbury; J P Brown; M Y Yeh; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

9.  Heparan sulfates from Swiss mouse 3T3 and SV3T3 cells: O-sulfate difference.

Authors:  K L Keller; J M Keller; J N Moy
Journal:  Biochemistry       Date:  1980-05-27       Impact factor: 3.162

10.  Cell adhesion and proteoglycans. I. The effect of exogenous proteoglycans on the attachment of chick embryo fibroblasts to tissue culture plastic and collagen.

Authors:  P Knox; P Wells
Journal:  J Cell Sci       Date:  1979-12       Impact factor: 5.285

View more
  15 in total

Review 1.  CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma.

Authors:  Matthew A Price; Leah E Colvin Wanshura; Jianbo Yang; Jennifer Carlson; Bo Xiang; Guiyuan Li; Soldano Ferrone; Arkadiusz Z Dudek; Eva A Turley; James B McCarthy
Journal:  Pigment Cell Melanoma Res       Date:  2011-12       Impact factor: 4.693

2.  CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix.

Authors:  C A Henke; U Roongta; D J Mickelson; J R Knutson; J B McCarthy
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

3.  Chondroitin sulfate proteoglycan 4 enhanced melanoma motility and growth requires a cysteine in the core protein transmembrane domain.

Authors:  Jianbo Yang; Matthew A Price; Leah E C Wanshura; Jinsong He; Mei Yi; Danny R Welch; Guiyuan Li; Sean Conner; Jonathan Sachs; Eva A Turley; James B McCarthy
Journal:  Melanoma Res       Date:  2019-08       Impact factor: 3.599

4.  Murine monoclonal anti-idiotope antibody breaks unresponsiveness and induces a specific antibody response to human melanoma-associated proteoglycan antigen in cynomolgus monkeys.

Authors:  P Chattopadhyay; J Starkey; W J Morrow; S Raychaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

5.  Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds.

Authors:  R O Schlingemann; F J Rietveld; R M de Waal; S Ferrone; D J Ruiter
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

6.  Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.

Authors:  A Mittelman; Z J Chen; H Yang; G Y Wong; S Ferrone
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

7.  Coordinate role for cell surface chondroitin sulfate proteoglycan and alpha 4 beta 1 integrin in mediating melanoma cell adhesion to fibronectin.

Authors:  J Iida; A P Skubitz; L T Furcht; E A Wayner; J B McCarthy
Journal:  J Cell Biol       Date:  1992-07       Impact factor: 10.539

8.  Expression and enhanced secretion of proteochondroitin sulphate in a metastatic variant of a mouse lymphoma cell line.

Authors:  R Schwartz-Albiez; I Steffen; A Lison; N Güttler; V Schirrmacher; R Keller
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

9.  Uncoupling of chondroitin sulfate glycosaminoglycan synthesis by brefeldin A.

Authors:  R C Spiro; H H Freeze; D Sampath; J A Garcia
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

10.  Nerve terminal anchorage protein 1 (TAP-1) is a chondroitin sulfate proteoglycan: biochemical and electron microscopic characterization.

Authors:  S S Carlson; T N Wight
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.